Search Within

Nancy Collins

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (4)
Groups
  1. Department of Medicine (9)
  2. GSK Faculty (9)
  3. Human Oncology and Pathogenesis Program (9)
  4. Immunology Program Faculty (9)
  5. Pediatrics, Department of (9)
  6. Sloan Kettering Institute Faculty (9)

More Groups

People
  1. Richard O'Reilly (9)
  2. Esperanza Papadopoulos (8)
  3. Ann Jakubowski (7)
  4. Hugo Castro-Malaspina (7)
  5. James Young (7)
  6. Katharine Hsu (7)

More People

Years
  1. 2011 (1)
  2. 2010 (1)
  3. 2008 (1)
  4. 2007 (2)
  5. 2006 (1)
  6. 2004 (1)

More Years

Publications
  1. Blood (5)
  2. Biology of Blood and Marrow Transplantation (3)
  3. Bone Marrow Transplantation (1)
Publishers
  1. American Society of Hematology (5)
  2. Elsevier Inc. (3)
  3. Nature Publishing Group (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies
    Journal Article

    Jakubowski, A. A.; Small, T. N.; Kernan, N. A.; Castro-Malaspina, H.; Collins, N.; Koehne, G.; Hsu, K. C.; Perales, M. A.; Papanicolaou, G.; van den Brink, M. R. M.; more...
    Biology of Blood and Marrow Transplantation (2011)

    Fulltext@MSK | Save
  • Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT
    Journal Article

    Perales, M. A.; Jenq, R.; Goldberg, J. D.; Wilton, A. S.; Lee, S. S. E.; Castro-Malaspina, H. R.; Hsu, K.; Papadopoulos, E. B.; van den Brink, M. R. M.; Boulad, F.; more...
    Bone Marrow Transplantation (2010)

    Fulltext@MSK | Save
  • Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings
    Journal Article

    Castro-Malaspina, H.; Jakubowski, A. A.; Papadopoulos, E. B.; Boulad, F.; Young, J. W.; Kernan, N. A.; Perales, M. A.; Small, T. N.; Hsu, K.; Chiu, M.; more...
    Biology of Blood and Marrow Transplantation (2008)

    Fulltext@MSK | Save
  • T cell-depleted stem-cell transplantation for adults with hematologic malignancies: Sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin
    Journal Article

    Jakubowski, A. A.; Small, T. N.; Young, J. W.; Kernan, N. A.; Castro-Malaspina, H.; Hsu, K. C.; Perales, M. A.; Collins, N.; Cisek, C.; Chiu, M.; more...
    Blood (2007)

    Fulltext@MSK | Save
  • Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure
    Journal Article

    Chewning, J. H.; Castro-Malaspina, H.; Jakubowski, A.; Kernan, N. A.; Papadopoulos, E. B.; Small, T. N.; Heller, G.; Hsu, K. C.; Perales, M. A.; van den Brink, M. R. M.; more...
    Biology of Blood and Marrow Transplantation (2007)

    Fulltext@MSK | Save
  • Results of T cell depleted (TCD) allogeneic hematopoietic stem cell transplantation (AlloHSCT) from HLA matched (HLA-M) or partially mismatched (HLA-MM) unrelated donors (URD) in patients with hematologic malignancies: Sustained engraftment and low incidence of graft-vs-host disease (GvHD)
    Meeting Abstract

    Jakubowski, A. A.; Papadopoulos, E. B.; Kernan, N. A.; Boulad, F.; Castro-Malaspina, H. R.; Collins, N. H.; Hsu, K.; Perales, M. A.; Small, T. N.; Van Den Brink, M.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • A phase II trial of busulfan, melphalan, and fludarabine followed by allogeneic T-cell depleted hematopoietic stem cell transplants from HLA-identical, or HLA-non identical related or unrelated donors for the treatment of advanced hematopoietic malignancies
    Meeting Abstract

    Boulad, F.; Jakubowski, A.; Castro-Malaspina, H.; Hsu, K. C.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M. A.; Prockop, S. E.; Small, T. N.; van den Brink, M. R. M.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Growth of Epstein-Barr virus-induced human B-cell lympho-proliferative disorders (EBV-LPD) in mice with severe combined immunodeficiency (SCID) is facilitated by depletion of mouse natural killer cell function with rabbit anti-asialo GM1 antiserum (α-asialo GM1)
    Meeting Abstract

    Lacerda, J. F.; Dennig, D.; Ladanyi, M.; Jagiello, C.; Nguyen, H.; Collins, N. H.; O'Reilly, R. J.
    Blood (1994)

    Fulltext@MSK | Save
  • Adoptive immunotherapy with human Epstein-Barr virus (EBV) specific cytotoxic T lymphocytes (CTL) for the treatment of severe combined Immunodeficiency (SCID) mice bearing human EBV-induced B-cell lymphoproliferative disorders (EBV-LPD)
    Meeting Abstract

    Lacerda, J. F.; Dennig, D.; Lucas, K.; Collins, N.; Ladanyi, M.; Papadopoulos, E.; O'Reilly, R. J.
    Blood (1994)

    Fulltext@MSK | Save